- Home
- PEB
as 12-18-2024 10:41am EST
Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,924 rooms across 46 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | BETHESDA |
| Market Cap: | 1.5B | IPO Year: | 2009 |
| Target Price: | $14.92 | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | -0.26 | EPS Growth: | N/A |
| 52 Week Low/High: | $11.65 - $16.65 | Next Earning Date: | 11-07-2024 |
| Revenue: | $1,449,797,000 | Revenue Growth: | 3.15% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 3.64% |
Latest Pebblebrook Hotel Trust of Beneficial Interest News
PEB Breaking Stock News: Dive into PEB Ticker-Specific Updates for Smart Investing
Business Wire
2 days ago
Pebblebrook Hotel Trust Declares Dividends for Fourth Quarter 2024
Argus Research
8 days ago
PEB: Raising target price to $16.00
Morningstar Research
8 days ago
Analyst Report: Pebblebrook Hotel Trust
Simply Wall St.
9 days ago
December 2024's Undervalued Small Caps With Insider Action In US
Argus Research
15 days ago
PEB: What does Argus have to say about PEB?
Morningstar Research
17 days ago
Analyst Report: Pebblebrook Hotel Trust
TipRanks
18 days ago
Pebblebrook Hotel price target raised to $16.25 from $15 at Stifel
Argus Research
22 days ago
PEB: Raising target price to $15.00
Compare PEB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PEB Pebblebrook Hotel Trust of Beneficial Interest - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.